您的购物车当前为空
别名 IPdR
Ropidoxuridine (IPdR) 是一种新型的、可口服的卤化胸苷类似物,有望成为人类肿瘤的增敏剂。Ropidoxuridine 是一种可口服且具有生物可利用的IUdR(5-碘-2'-脱氧尿苷)前药。


为众多的药物研发团队赋能,
让新药发现更简单!
Ropidoxuridine (IPdR) 是一种新型的、可口服的卤化胸苷类似物,有望成为人类肿瘤的增敏剂。Ropidoxuridine 是一种可口服且具有生物可利用的IUdR(5-碘-2'-脱氧尿苷)前药。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 377 | In Stock | |
| 5 mg | ¥ 1,030 | In Stock | |
| 10 mg | ¥ 1,660 | In Stock | |
| 25 mg | ¥ 2,670 | In Stock | |
| 50 mg | ¥ 3,660 | In Stock | |
| 100 mg | ¥ 4,910 | In Stock | |
| 200 mg | ¥ 6,620 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,130 | In Stock |
Ropidoxuridine 相关产品
| 产品描述 | Ropidoxuridine (IPdR) is a novel, orally available halogenated thymidine analogue that holds promise as a sensitizer for human tumors.Ropidoxuridine is an orally available and bioavailable IUdR (5-iodo-2'-deoxyuridine) prodrug. |
| 体外活性 | Ropidoxuridine是IUdR的一种口服生物可用前药。在临床相关浓度下,Ropidoxuridine与Alisertib展现出明显的协同效应。[1] |
| 体内活性 | Ropidoxuridine (750 mg/kg/日) 与 Alisertib (30 mg/kg/日) 在正位肿瘤模型中展示了强烈的协同效应。[1] |
| 别名 | IPdR |
| 分子量 | 338.1 |
| 分子式 | C9H11IN2O4 |
| CAS No. | 93265-81-7 |
| Smiles | OC[C@H]1O[C@H](C[C@@H]1O)n1cc(I)cnc1=O |
| 密度 | 2.22g/cm3 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 225.0 mg/mL (665.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容